Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Post by somweyungguyon Oct 05, 2016 7:38pm

140 Views

Post# 25314569

Medwell deal from Mavrix

Just to add insult to injury...

Medwell ( BioMS ) had done their original deal at 40 cents and were soon after given a hefty raise by us ( SDI ) to guide and act as our consultant.

Get this...

After a year of "bringing value" to us, they bought the entire Mavrix position for 30 a share or 25% below their original investment despite being paid 1.5M to consult and AD VALUE

THEY OWN IT ALL and will stop at nothing to gain more CONTROL

Sick and very real

Sqr

Bullboard Posts

@ the Bell: TSX advances to start off Christmas trading week